401 related articles for article (PubMed ID: 21735432)
41. Intratympanic corticosteroids injections: a systematic review of literature.
Lavigne P; Lavigne F; Saliba I
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2271-8. PubMed ID: 26100030
[TBL] [Abstract][Full Text] [Related]
42. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].
Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195
[No Abstract] [Full Text] [Related]
43. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
[TBL] [Abstract][Full Text] [Related]
44. Intratympanic Treatment in Menière's Disease, Efficacy of Aminoglycosides Versus Corticosteroids in Comparison Studies: A Systematic Review.
Yaz F; Ziylan F; Smeeing DPJ; Thomeer HGXM
Otol Neurotol; 2020 Jan; 41(1):1-10. PubMed ID: 31789967
[TBL] [Abstract][Full Text] [Related]
45. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of transtympanic dexamethasone perfusion using the MicroWick
Kim CS; Martinez U; Mulvey E; Nayak N; Silverstein H
Am J Otolaryngol; 2021; 42(5):103138. PubMed ID: 34214774
[TBL] [Abstract][Full Text] [Related]
47. Intratympanic gentamicin compared with placebo for Ménière's disease.
de Amesti F; Santander MJ; Winter M
Medwave; 2022 Mar; 22(2):e8696. PubMed ID: 35323825
[TBL] [Abstract][Full Text] [Related]
48. Short Term Results of Intra Tympanic Gentamicin and Dexamethasone on Hearing and Tinnitus in Meniere's disease: A Case Control Study.
Shamas IU
Int Tinnitus J; 2017 Jun; 21(1):21-23. PubMed ID: 28723597
[TBL] [Abstract][Full Text] [Related]
49. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
[TBL] [Abstract][Full Text] [Related]
50. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
[TBL] [Abstract][Full Text] [Related]
51. Steroids for idiopathic sudden sensorineural hearing loss.
Wei BP; Stathopoulos D; O'Leary S
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003998. PubMed ID: 23818120
[TBL] [Abstract][Full Text] [Related]
52. Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease: a network meta-analysis.
Hao W; Yu H; Li H
J Neurol; 2022 Jan; 269(1):72-86. PubMed ID: 33387016
[TBL] [Abstract][Full Text] [Related]
53. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
54. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
Gabra N; Saliba I
Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
Liu YF; Renk E; Rauch SD; Xu HX
Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
[TBL] [Abstract][Full Text] [Related]
56. Intratympanically administered steroid for progressive sensorineural hearing loss in Ménière's disease.
Molnár A; Maihoub S; Tamás L; Szirmai Á
Acta Otolaryngol; 2019 Nov; 139(11):982-986. PubMed ID: 31498001
[No Abstract] [Full Text] [Related]
57. Intratympanic Steroid for Menière's Disease: A Systematic Review.
Devantier L; Djurhuus BD; Hougaard DD; Händel MN; Guldfred FL; Schmidt JH; Edemann-Callesen H
Otol Neurotol; 2019 Jul; 40(6):806-812. PubMed ID: 31135678
[TBL] [Abstract][Full Text] [Related]
58. Patients' subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Ménière's disease.
Söderman AC; Bergenius J; Bagger-Sjöbäck D; Tjell C; Langius A
Otol Neurotol; 2001 Jul; 22(4):526-33. PubMed ID: 11449112
[TBL] [Abstract][Full Text] [Related]
59. [Intratympanic dexamethasone injections for intractable Meniere's disease].
Lu Y; Ren J; Wu W; Yin T; Yang X; Xie D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):385-7. PubMed ID: 15499973
[TBL] [Abstract][Full Text] [Related]
60. Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease.
Masoumi E; Dabiri S; Khorsandi Ashtiani MT; Erfanian R; Sohrabpour S; Yazdani N; Safaee A; Firouzifar M
Iran J Otorhinolaryngol; 2017 Nov; 29(95):341-346. PubMed ID: 29383315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
